Interleukin-34 levels are increased in acute myocardial infarction and associated with major adverse cardiovascular events

MLA

Kashiwagi, Manabu, et al. “Interleukin-34 Levels Are Increased in Acute Myocardial Infarction and Associated with Major Adverse Cardiovascular Events.” Coronary Artery Disease, vol. 31, no. 1, Jan. 2022, pp. 61–63. EBSCOhost, https://doi.org/10.1097/MCA.0000000000001046.

APA

Kashiwagi, M., Ozaki, Y., Imanishi, T., Taruya, A., Kuroi, A., Katayama, Y., Shimamura, K., Shiono, Y., Tanimoto, T., Kubo, T., Tanaka, A., & Akasaka, T. (2022). Interleukin-34 levels are increased in acute myocardial infarction and associated with major adverse cardiovascular events. Coronary Artery Disease, 31(1), 61–63. https://doi.org/10.1097/MCA.0000000000001046

Chicago

Kashiwagi, Manabu, Yuichi Ozaki, Toshio Imanishi, Akira Taruya, Akio Kuroi, Yosuke Katayama, Kunihiro Shimamura, et al. 2022. “Interleukin-34 Levels Are Increased in Acute Myocardial Infarction and Associated with Major Adverse Cardiovascular Events.” Coronary Artery Disease 31 (1): 61–63. doi:10.1097/MCA.0000000000001046.